Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

Schizophrenia is a complex mental health condition characterized by a disruption in a person’s thoughts, perceptions, emotions, and behavior. It can be a debilitating condition, but with proper ...

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial. The negative outcome ...

A University of Kentucky researcher is leading a team in what the university calls a groundbreaking study. According to UK, the study identifies biological markers for schizophrenia, which could ...

Schizophrenia affects 1% of the global population and is caused by a complex interplay between at least 280 genes and environmental factors like childhood trauma and early cannabis use. Patients with ...

Schizoaffective disorder and schizophrenia have several symptoms in common, like hallucinations, delusions, and disorganized thinking or behavior. But although these conditions may resemble each other ...

Researchers have found statistically significant links between a gene tied to schizophrenia risk and poorer cognitive ...

The symptoms of schizophrenia vary greatly from person to person, and a newly reported international multicenter study, headed by a research team at the University of Zurich, has found that these ...

Researchers found a grin2a mutation disrupts a brain circuit that updates beliefs using new information. In mice, restoring ...